Abstract
Second Generation Proteasome Inhibitor is More Potent than Doxorubicin (Firstline Drug) in Inhibiting Proliferation and Inducing Apoptosis in Human Triplenegative Breast MDAMB231 Cancer Cells
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have